Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Accounts Payables (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Accounts Payables for 5 consecutive years, with $1.5 million as the latest value for Q3 2020.

  • On a quarterly basis, Accounts Payables fell 34.02% to $1.5 million in Q3 2020 year-over-year; TTM through Sep 2020 was $1.5 million, a 34.02% decrease, with the full-year FY2019 number at $1.6 million, down 53.91% from a year prior.
  • Accounts Payables was $1.5 million for Q3 2020 at Forte Biosciences, down from $2.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.6 million in Q3 2018 to a low of $947000.0 in Q1 2017.
  • A 5-year average of $2.1 million and a median of $1.7 million in 2016 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: surged 294.71% in 2018, then plummeted 53.91% in 2019.
  • Forte Biosciences' Accounts Payables stood at $1.7 million in 2016, then rose by 17.11% to $2.0 million in 2017, then skyrocketed by 74.47% to $3.4 million in 2018, then plummeted by 53.91% to $1.6 million in 2019, then decreased by 3.57% to $1.5 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Accounts Payables are $1.5 million (Q3 2020), $2.6 million (Q2 2020), and $1.6 million (Q1 2020).